Biotech
BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 11/25/16 -- Marina Biotech, Inc. (OTCQB: MRNA) today announced that its CEO, Joseph W. Ramelli, will be presenting at the LD Micro Main Event on Thursday, December 8, ...
GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 11/24/16 --AIM: AGL OTCQX: ANPCY("ANGLE" or "the Company")ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 11/23/16 --(TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializati ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 11/22/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 11/22/16 -- (NASDAQ: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the 28th Annual Piper Jaffray Healthcare ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 11/22/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy com ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 11/21/16 -- Opthea Limited (ASX: OPT), a developer of novel biologic therapies for the treatment of eye diseases, has completed patient enrolment in the rando ...
BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 11/16/16 -- Marina Biotech, Inc. (OTCQB: MRNA) today announced that it has signed a definitive merger agreement with IthenaPharma Inc., a company focused on the develo ...
MONTREAL, QUEBEC: First oral bivalent live vaccine for immunization of pigs against F4 and F18 Escherichia coli post-weaning diarrhea ...
SEATTLE, WA: Conference Call to be Held Monday, November 14, 2016 at 5:30pm Eastern Time ...
HUDSON, NY: Models Were Custom Generated by Taconic and Validated in Collaboration with Innovative Medicines Initiative (IMI) ...
LEXINGTON, MA: On Track to Initiate Two Phase II and Two Phase III Trials in 2017 ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 11/14/16 -- Immunovaccine Inc. (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will participate in the ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 11/10/16 -- iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced completion of ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 11/10/16 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") is scheduled to present at the Society of Neuro-Oncology Annual Meeting on Friday ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 11/10/16 -- (NASDAQ: ATOS) announced today that it will provide a Company update and discuss third quarter 2016 financial results on Monday, November 14, 2016 at 5:30 ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/10/16 --Trillium Therapeutics Inc. (Nasdaq: TRIL)(TSX: TR), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer ...
MONTREAL, QUEBEC: Ibalizumab Maintains Significant Reduction of Viral Load in Patients with Multi-Drug Resistant HIV-1 Over 24 Weeks. Results from the Study Support the Regulatory Submission of the BLA to the US FDA. ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 11/09/16 -- Flamel Technologies (NASDAQ: FLML) today announced that management will present at the Jefferies 2016 London Healthcare Conference. Michael Anderson, Chie ...
